Current changes in technology and the impact of the COVID pandemic has greatly accelerated the adoption of RBM methodology and AI/ML assisted risk analysis.

How are these changing directly impacting your future clinical trials as the industry is reorienting itself around a new normal with regards to monitoring and insights provided by integrated data reviews. This webinar will share how to:

• Monitoring – SDV reduction/remote SDM…How we monitor clinical trials is currently going through major changes in the wake of technological advances but also due to the ongoing pandemic. How can we all realign on the processes to ensure we deploy the most suitable techniques for the tasks at hand?
• Data integration…To make the most of the data being generated on clinical trials today the capacity for direct data integration is key to allow for a streamlined and productive use of insights generated from this data.
• AI/ML…Artificial Intelligence and Machine Learning are broad concepts but in the world of clinical research there is a significant portion of the work being done to analyze and identify risks which could directly benefit from utilizing these approaches to data, saving time and improving quality while keeping the human component at its core.

Register now

To hear the latest capabilities that are changing how clinical trials are being delivered with better, more timely patient insights enhancing patient safety and improving overall study quality.

Register now

Who should attend:

Clinical Operations leads/directors/VPs, Project Leads, Therapeutic heads, Outsourcing/Partners/Partnerships, Data management, Biostatistics Safety, Pharmacovigilance, clinical Innovation leaders.

Speakers

Lois Silk
Associate Director, Risk Based Monitoring

Jonas Renström
Director, Global Site Management and Centralized Monitoring